Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Vivace Therapeutics

HQ: San Mateo, CA source · vivacetherapeutics.com ↗

Clinical Phase 3

Keywords: small molecule oncology tumors Mesothelioma Pleural Mesothelioma NSCLC VT3989

Location: San Mateo, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

2Trials (company is sponsor)

Timeline

Dec 1, 2026 Trial start 3: A Phase 3 Trial in Advanced Epithelioid Mesothelioma source ↗
Mar 24, 2021 Trial start Phase 1/Phase 2: Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors source ↗

Upcoming milestones

May 1, 2028 (ESTIMATED) · 3 · A Phase 3 Trial in Advanced Epithelioid Mesothelioma · NCT07824986
Nov 2, 2029 (ESTIMATED) · Phase 1/Phase 2 · Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors · NCT04665206

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT07824986	A Phase 3 Trial in Advanced Epithelioid Mesothelioma	3	Not yet recruiting	Dec 1, 2026	May 1, 2028 (estimated)
NCT04665206	Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors	Phase 1/Phase 2	Recruiting	Mar 24, 2021	Nov 2, 2029 (estimated)